SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients
NCT06029179
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Hyperkalemia
Interventions
DRUG:
sodium zirconium cyclosilicate (SZC)
DRUG:
sodium polystyrene sulfonate
Sponsor
Alexandria University